Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation

- Zhang X. , et al.

2. Delayed brain metastasis in recurrent hepatocellular carcinoma following liver transplantation: a case report highlighting the predictive value of microvascular invasion

- Anisetti B. , et al.

3. CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes

- Ning Q. , et al.

4. Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma

- Lima H.A. , et al.

5. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial

- Zheng D.h. , et al.

6. Adjuvant treatment of hepatocellular carcinoma after resection

- Brown Z.J. , et al.

7. Long-term clinical benefit of Peg-IFNα and NAs sequential antiviral therapy oHBV related HCC

- Qi W.Q. , et al.

8. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation

- Wang M.X. , et al.

9. Peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma patients after hepatectomy/ablation

- Qi W. , et al.

10. Microrna-98-5p inhibits tumorigenesis of hepatitis b virus-related hepatocellular carcinoma by targeting nf-κb-inducing kinase

- Fei X. , et al.

11. Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy

- Brown Z.J. , et al.

12. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study

- El-Houseini M.E. , et al.

13. Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence

- Pazgan-Simon M. , et al.

14. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma

- Jiang E. , et al.

15. Microwave ablation-assisted liver gene transfection in rats

- Jiang R. , et al.

16. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects

- Du Y. , et al.

17. DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

- Liu H. , et al.

18. APOBEC3B: A potential factor suppressing growth of human hepatocellular carcinoma cells

- Wu P.F. , et al.

19. Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development

- Tu T. , et al.

20. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma

- Deng Y. , et al.

21. Effect of nucleoside analog use in patients with hepatitis B virus-related hepatocellular carcinoma

- Nishikawa H. , et al.

22. Anti-HBV treatment delays development and evolution of HCC

- Yang F. , et al.

23. Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: A single institution's experience with 398 consecutive patients

- Du Z.G. , et al.

24. The preventive transhepatic interventional therapy for primary liver cancer after surgical resection: Comparison study between TACE and TAI

- Feng C. , et al.

25. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects

- Lee S.C. , et al.